Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Ekso Bionics Holdings Inc
NASDAQ:CHRN

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:CHRN
Watchlist
Price: 20.13 USD 7.94% Market Closed
Market Cap: $2.9B
Write Note Create Alert Ask AI

Wall St Price Targets

CHRN Price Targets Summary
Ekso Bionics Holdings Inc

Wall Street analysts forecast CHRN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHRN is 9.69 USD with a low forecast of 9.6 USD and a high forecast of 9.98 USD.

CHRN Lowest Forecast
Wall Street Target
$9.6
-52% Downside
CHRN Average Forecast
Wall Street Target
$9.69
-52% Downside
CHRN Highest Forecast
Wall Street Target
$9.98
-50% Downside
Lowest Forecast
Price Target
9.6 USD
52% Downside
Average Forecast
Price Target
9.69 USD
52% Downside
Highest Forecast
Price Target
9.98 USD
50% Downside
Ekso Bionics Holdings Inc Competitors:
Price Targets

Revenue
Forecast

8% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
8% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 35%.

What are analyst estimates?

Gross Profit
Forecast

14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Ekso Bionics Holdings Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Ekso Bionics Holdings Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss

What are analyst estimates?

Continue CHRN Research

Summary
CHRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHRN stock valuation using valuation multiples.
Wall St Estimates
CHRN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Ekso Bionics Holdings Inc listings:
LSE • USD
0IFR
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CHRN's stock price target?
Price Target
9.69 USD

According to Wall Street analysts, the average 1-year price target for CHRN is 9.69 USD with a low forecast of 9.6 USD and a high forecast of 9.98 USD.

What is the Revenue forecast for Ekso Bionics Holdings Inc?
Projected CAGR
35%

Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 35%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.